Connection | Reflection | Projection

LIVE ONLINE 20 May 2021

catch up: view 2021 on demand

Bio Integrates 2021 Agenda

20 May 2021

PANEL DISCUSSIONS AND WORKSHOPS

PLEASE NOTE This event is now closed. You can catch up and view on demand

SESSIONS WILL BE DIVIDED INTO 3 TRACKS PRIOR TO THE EVENT.

DELEGATES WILL BE FREE TO CHOOSE FROM TRACK 1, 2 or 3 AT ANY TIME.

THE DAY WILL START WITH OPENING REMARKS AND CONCLUDE WITH A

NETWORKING SESSION FINISHING AT 17:00.

08:45 – 09:00

Welcome and opening remarks

Andy Richards

09:00 – 09:20

A fireside chat with Ian McCubbin

Interview conducted by Martino Picardo, Chairman, Discovery Park

09:25 – 09:45

A fireside chat with Eliot Forster

Interview conducted by Martino Picardo, Chairman, Discovery Park

CONNECTION

Finding the right investors, partners and vendors is key to accelerating your products. How do you make the best connections?

Session 1

09:50 – 10:40

Collaboration for the nation

C-Suite Series & Networking

11:15 – 12:05

Assuring Patient Access in a post COVID World

12:15 – 13:05

Planting the seed

13:15 – 14:05

Growing pains

14:05 – 14:55

It ain’t what you do
it’s the way that you do it

15:03 – 15:55

Start with an end in mind

Virtual Drinks Reception with Closing Remarks from
Martino Picardo

REFLECTION

2020 was an unprecedented year. What impact has it had on biotech funding, pipelines and ecosystem?

Session 1

09:50 – 10:40

Never let a crisis go to waste

C-Suite Series & Networking

11:15 – 12:05

It’s about time

12:15 – 13:05

Should I stay or should I go?

Networking

Session 4

14:05 – 14:55

Leading Change into a new world

15:05 – 15:55

Next in the series…..

Virtual Drinks Reception with Closing Remarks

PROJECTION

What does the future hold for life science investment and infrastructure?

Session 1

09:50 – 10:40

If you build it, they will come

C-Suite Series & Networking

11:15 – 12:05

Recruit, reward, retain

12:15 – 13:05

Playing catch up

Networking

Session 4

14:05 – 14:55

Playing it cool

15:05 – 15:55

Mind the gap

Virtual Drinks Reception with Closing Remarks

Welcome and opening remarks

Andy RIchards

A fireside chat with Ian McCubbin

Interview conducted by Martino Picardo, Chairman, Discovery Park

A fireside chat with Eliot Forster

Interview conducted by Martino Picardo, Chairman, Discovery Park

CONNECTION

Finding the right investors, partners and vendors is key to accelerating your products. How do you make the best connections?

Session 1:

09:50 – 10:40

Collaboration for the nation

C-Suite Series & Networking

11:15 – 12:05

Assuring Patient Access

12:15- 13:05

Planting the seed

13:15- 14:05

Growing pains

14:05 – 14:55

It ain’t what you do it’s the way that you do it

15:05 – 15:55

Start with an end in mind

Virtual Drinks Reception with Closing Remarks

Join

REFLECTION

2020 was an unprecendent year. What impact has it had on biotech funding, pipelines and ecosystem?

Session 1:

09:50 – 10:40

Never let a crisis go to waste

C-Suite Series & Networking

11:15 – 12:05

It’s about time

12:15 – 13:05

Should I stay or should I go?

Networking

Join

Session 4:

14:05 – 14:55

Leading Change into a new world

15:05 – 15:55

Next in the series…..

Virtual Drinks Reception

Join

PROJECTION

What does the future hold for life science investment and infrastructure?

Session 1:

09:50 – 10:40

If you build it, they will come

C-Suite Series & Networking

11:15 – 12:05

Recruit, reward, retain

12:15 – 13:05

Playing catch up

Networking

Join

Session 4:

14:05 – 14:55

Playing it cool

15:05 – 15:55

Mind the gap

Virtual Drinks Reception

Join

Our Valued Gold Sponsor

CATCH UP
View Bio Integrates 2021
On Demand

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

Connection | Reflection | Projection

LIVE ONLINE 20 May 2021

view 2021 speakers

View 2021 agenda

Collaboration for the nation

Coronavirus vaccines have demonstrated just how key collaborations are. Should we be doing more, and what makes them effective?

FACILITATED BY

JAMES FRY | Partner and Head of Life Sciences | Mills & Reeve

PANELLISTS INCLUDE

The Global Biopharma Resilience Index

Cytiva’s Global Biopharma Resilience Index - based on a survey of more than 1,000 senior biopharma executives - takes a holistic look at the industry across five key pillars at a time when its health is vital. Fresh data shows there is work to be done to secure its future.

Emmanuel will speak about the challenges in the industry and what we can do to meet them.

EMMANUEL LIGNER | President and Chief Executive Officer | Cytiva

Hosted on our popular networking platform

Assuring Patient Access in a COVID World

What requirements do Biotech companies need to consider during clinical development to ensure that patients will gain access to their innovative therapies? How must Biotech companies adapt in order to be successful in an increasingly cost-conscious world?

FACILITATED BY

MEL WALKER | Managing Director | BioPharma Futures

PANELLISTS INCLUDE

Planting the seed

What does it take to raise seed funding, and what do you need to demonstrate for angels/investors to part with their money?

FACILITATED BY

JONATHAN APPLEBY | Chief Scientific Officer | Cell and Gene Therapy Catapult (CGT Catapult)

PANELLISTS INCLUDE

Growing pains

How, where, when and if to grow are decisions critical to the success of all biotech focused companies – spanning products to services. How do you plan, implement and adapt your growth strategy?

Value creation through growth is an imperative for all companies. What strategies work best in the biotech world?
Strategies invariably evolve over time. We will hear from companies that have pivoted from service to product - and vice versa. Is this by design or by necessity?
Self-proclaimed serial entrepreneurs are abundant. Where are the serial scalers? Do they exist? Are they hidden? Are they tied up in longer-term projects?
What tools and techniques exist to support the development of growth strategies? What works? Are they transferable?

FACILITATED BY

KEVIN COX | Chair | Biorelate

PANELLISTS INCLUDE

It ain't what you do it's the way that you do it

With so many CDMOs providing the same services, how do they differentiate their offering? And how do biotechs chose the right one to work with?

FACILITATED BY

RICHARD WILLIAMS | SVP CMC & Development | Crescendo Biologics

PANELLISTS INCLUDE

Start with an end in mind

Should our products be patient-focused from the start, or should we be more mindful of milestones at the outset?

FACILITATED BY

JESÚS ZURDO | Global Head Cell, Gene Therapy & Bioproduction | Horizon Discovery

PANELLISTS INCLUDE

Never let a crisis go to waste

Raising investment and meeting milestones is difficult enough in normal times. We hear from those who have thrived through the pandemic.

FACILITATED BY

ZAHID MONEER | Head of Healthcare, Investment Banking Division | BNP Paribas

PANELLISTS INCLUDE

It's about time

COVID-19 vaccines have shown the public just how fast we can develop, assess and approve medicines. How can we accelerate these timelines outside of a pandemic?

FACILITATED BY

IAN MUIR | Chief Executive Officer | Porton Biopharma

PANELLISTS INCLUDE

Should I stay or should I go?

Brexit and the imminent funding gap has led to companies looking to locate elsewhere. We hear from countries/regions trying to attract Life Science companies.

FACILITATED BY

KATH MACKAY | Managing Director | Bruntwood SciTech – Alderley Park

PANELLISTS INCLUDE

Leading Change into a new world

Faced with ongoing change what have we learnt that will serve us well as we lead in 2021 and beyond…

• Why will leading change continue to be important in 2021 and beyond?
• How can we reset and reenergize?
• What are the key success factors in leading change?

FACILITATED BY

KATHRYN SIMPSON | Business Consultant | Kathryn Simpson Consulting

PANELLISTS INCLUDE

Next in the series.....

£1m - £5m is the new funding valley of death. How do you effectively position your business for Series A funds, and how do you select investors that are right for you?

FACILITATED BY

JANE DANCER | Independent Consultant

PANELLISTS INCLUDE

If you build it, they will come.

The UK Government has launched a £20M fund to grow medicines manufacturing. Is this enough to secure supplies and to attract inward investment?

FACILITATED BY

IAN CAMPBELL | Chief Business Officer | LifeArc

PANELLISTS INCLUDE

Recruit, reward, retain

Will Brexit limit the UK's ability to recruit and retain talent? What areas of life science should we focus on for training and upskilling?

FACILITATED BY

ELEANOR DAVIES | Managing Partner | The RSA Group

PANELLISTS INCLUDE

Playing catch up

With attention and funding diverting to vaccines in 2020, other disease areas like oncology have been left behind. How can we ensure they catch up?

FACILITATED BY

EMMA PALMER FOSTER | Strategic Communications Consultant | The Oxford Science Park

PANELLISTS INCLUDE

Playing it cool

Vaccine supply has demonstrated the importance of cold chain and agile supply chains. Do we have the infrastructure to supply, and ensure security? How can we build a robust supply chain to ensure medicines delivery doesn’t become rate-limiting?

FACILITATED BY

JOHN VANDORE | Business Development | Harwell Campus

PANELLISTS INCLUDE

Mind the gap

With increased public funding in coronavirus detection and vaccines, and restrictions on funding from the EU, will there be a major gap in life science funding?

FACILITATED BY

RICHARD HEBDON | Interim Deputy Director - Health & Life Sciences | Innovate UK

PANELLISTS INCLUDE

LIVE ONLINE 20 May 2021

Bio Integrates 2021 Agenda

20 May 2021

PANEL DISCUSSIONS AND WORKSHOPS

PLEASE NOTE This event is now closed. You can catch up and view on demand

SESSIONS WILL BE DIVIDED INTO 3 TRACKS PRIOR TO THE EVENT.

DELEGATES WILL BE FREE TO CHOOSE FROM TRACK 1, 2 or 3 AT ANY TIME.

THE DAY WILL START WITH OPENING REMARKS AND CONCLUDE WITH A

NETWORKING SESSION FINISHING AT 17:00.

08:45 – 09:00

Welcome and opening remarks

09:00 – 09:20

A fireside chat with Ian McCubbin

09:25 – 09:45

A fireside chat with Eliot Forster

CONNECTION

Session 1

09:50 – 10:40

Collaboration for the nation

10:40 – 11:15

C-Suite Series & Networking

Session 2

11:15 – 12:05

Assuring Patient Access in a post COVID World

Session 3

12:15 – 13:05

Planting the seed

Session 4

13:15 – 14:05

Growing pains

Session 5

14:05 – 14:55

It ain’t what you do it’s the way that you do it

Session 6

15:03 – 15:55

Start with an end in mind

16:00 – 16:40

Virtual Drinks Reception with Closing Remarks fromMartino Picardo

REFLECTION

Session 1

09:50 – 10:40

Never let a crisis go to waste

10:40 – 11:15

C-Suite Series & Networking

Session 2

11:15 – 12:05

It’s about time

Session 3

12:15 – 13:05

Should I stay or should I go?

13:15 – 14:05

Networking

Session 4

14:05 – 14:55

Leading Change into a new world

Session 5

15:05 – 15:55

Next in the series…..

16:00 – 16:40

Virtual Drinks Reception with Closing Remarks

PROJECTION

Session 1

09:50 – 10:40

If you build it, they will come

10:40 – 11:15

C-Suite Series & Networking

Session 2

11:15 – 12:05

Recruit, reward, retain

Session 3

12:15 – 13:05

Playing catch up

13:15 – 14:05

Networking

Session 4

14:05 – 14:55

Playing it cool

Session 5

15:05 – 15:55

Mind the gap

It ain’t what you do
it’s the way that you do it

Virtual Drinks Reception with Closing Remarks from
Martino Picardo